Stay updated with breaking news from Hermes Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
.jpg)
CDMO and full service provider Hermes Pharma is investing a further €25 million in its manufacturing capabilities, arming the company with new equipment, increased production and storage capacity, as well as greater operational efficiency to meet the rapidly growing market demand for user-friendly oral dosage forms. Click to read more...
Wealthy individuals are demanding refunds that range from $50,000 to nearly $2 million, after company searches revealed Aurum+ has only ever issued 100 shares at $1 each.
How about a well-assessed report on the Effervescent Tablet Manufacturing Services Market that provides insightful analysis of various trends, service